151 results on '"Hua, Lingyang"'
Search Results
2. Intracranial angioleiomyoma mimicking meningioma: an uncommon tumor with favorable outcome and frequent GJA4 mutation
3. Predicting meningioma grades and pathologic marker expression via deep learning
4. Prognostic models for progression-free survival in atypical meningioma: Comparison of machine learning-based approach and the COX model in an Asian multicenter study
5. The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study
6. Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk
7. Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype
8. Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma
9. Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma
10. LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway
11. Clinical and molecular characteristics and long-term outcomes of pediatric intracranial meningiomas: a comprehensive analysis from a single neurosurgical center.
12. Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord
13. IRAK4 exacerbates traumatic brain injury via activation of TAK1 signaling pathway
14. Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma
15. Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas
16. The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study
17. A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma
18. β1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells
19. PATH-51. GENETIC CHARACTERIZATION AND MUTATIONAL PROFILING OF FORAMEN MAGNUM MENINGIOMAS: A MULTI-INSTITUTIONAL STUDY
20. CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis
21. Angiomatous Meningiomas Have a Very Benign Outcome Despite Frequent Peritumoral Edema at Onset
22. Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center
23. Frequent NF2 mutations contribute to spinal location predominance and worse outcomes in psammomatous meningiomas
24. Prognostic Factors in Patients with Primary Hemangiopericytomas of the Central Nervous System: A Series of 103 Cases at a Single Institution
25. Ash1L Ameliorates Psoriasis via Limiting Neuronal Activity-Dependent Release of miR-let-7b
26. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes
27. Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk
28. Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection
29. SURG-11. AKT1 E17K AND NF2 MUTATIONS DOMINATE SPINAL MENINGIOMAS WHO GRADE 1 AND PRESENT DISTINCT TUMOR FEATURES
30. Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas
31. Regulation and roles of RNA modifications in aging‐related diseases
32. AKT1E17K- und NF2-Mutationen sind die Hauptereignisse bei spinalen Meningeomen und sind mit unterschiedlichen Tumormerkmalen assoziiert
33. Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype
34. miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells
35. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.
36. Microcystic Meningioma Has A Worse Outcome Than Other WHO Grade 1 Subtypes
37. m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes
38. TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy
39. MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma
40. Molecular diagnosis and treatment of meningiomas: an expert consensus (2022).
41. Letter to the Editor Regarding “Stereotactic Radiosurgery for Atypical and Anaplastic Meningiomas”
42. Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
43. High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
44. m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.
45. Long-term outcomes of multimodality management for parasagittal meningiomas
46. The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations
47. The Diagnostic Value Of Using 18F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma
48. Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application
49. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
50. Intra-operative motor function preservation for resection of primary motor cortex meningioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.